We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hamburg: Sharing Review Data Is New ‘Frontier’ for Transparency
Hamburg: Sharing Review Data Is New ‘Frontier’ for Transparency
May 11, 2012
Drugmakers and the rest of the scientific community can and should benefit from the careful disclosure of FDA review data that industry and the agency currently keep closely guarded, FDA Commissioner Margaret Hamburg says.